Advertisement

Cartilage pp 191-227 | Cite as

The Sensory and Sympathetic Nervous System in Cartilage Physiology and Pathophysiology

  • Susanne Grässel
  • Rainer H. Straub
  • Zsuzsa Jenei-Lanzl
Chapter

Abstract

The peripheral nervous system is critically involved in metabolism of joint tissue and intervertebral disks (IVD). Nerve fibers of sympathetic and sensory origin innervate synovial tissue and subchondral bone of diarthrodial joints. In pathophysiological situations as in osteoarthritis (OA), rheumatoid arthritis (RA), and IVD degeneration, innervation patterns of sympathetic and sensory nerve fibers are partly altered in joint tissue and IVD.

Various resident cell types of the musculoskeletal system express receptors for sensory and sympathetic neurotransmitters allowing response to neuronal stimuli. Among them are mesenchymal stem cells, synovial fibroblasts, bone cells, and different types of chondrocytes, which express distinct subtypes of adrenoceptors, receptors for vasoactive intestinal peptide (VIP), for substance P (SP), and calcitonin gene-related peptide (CGRP). Some of these cell types even synthesize neuropeptides such as SP, and they are positive for tyrosine hydroxylase (TH), the rate limiting enzyme for biosynthesis of catecholamines. During endochondral ossification in embryonic limb development, sensory and sympathetic neurotransmitters modulate osteo-chondrogenic differentiation of mesenchymal progenitor cells, vascularization, and matrix differentiation indicating a distinct role in skeletal growth and possible limb regeneration processes. In adults, sensory and sympathetic neurotransmitters are involved in pathology of inflammatory diseases as rheumatoid arthritis which manifests mainly in joints. In addition, they might play a role in pathogenesis of a priori degenerative joint disorders, as osteoarthritis and intervertebral disk degeneration.

Altogether it became evident that sensory and sympathetic neurotransmitters have crucial trophic effects which are critical for proper limb formation during embryonic skeletal growth. In adults, they modulate articular cartilage, subchondral bone and synovial tissue homeostasis, and physiological and pathophysiological conditions, in addition to their classical neurological features.

Keywords

Nerve Fiber Nerve Growth Factor Articular Cartilage Vasoactive Intestinal Peptide Annulus Fibrosus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

The authors are supported by the DFG grants to SG (GR 1301-19) and to ZJL (JE 642/4-1), both subprojects of FOR 2407-1.

References

  1. Ahn SH, Cho YW, Ahn MW, Jang SH, Sohn YK, Kim HS (2002) mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine (Phila Pa 1976) 27(9):911–917CrossRefGoogle Scholar
  2. Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R (1992) Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum 35(3):351–355PubMedCrossRefGoogle Scholar
  3. Aloe L, Probert L, Kollias G, Bracci-Laudiero L, Spillantini MG, Levi-Montalcini R (1993) The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor. Growth Factors 9(2):149–155PubMedCrossRefGoogle Scholar
  4. Antonioli L, Colucci R, La Motta C, Tuccori M, Awwad O, Da Settimo F, Blandizzi C, Fornai M (2012) Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders. Curr Drug Targets 13(6):842–862PubMedCrossRefGoogle Scholar
  5. Ashraf S, Mapp PI, Walsh DA (2011a) Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis. Arthritis Rheum 63(9):2700–2710. doi: 10.1002/art.30422 PubMedCrossRefGoogle Scholar
  6. Ashraf S, Wibberley H, Mapp PI, Hill R, Wilson D, Walsh DA (2011b) Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis. Ann Rheum Dis 70(3):523–529. doi: 10.1136/ard.2010.137844 PubMedCrossRefGoogle Scholar
  7. Baillie GS, Sood A, McPhee I, Gall I, Perry SJ, Lefkowitz RJ, Houslay MD (2003) Beta-arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc Natl Acad Sci U S A 100(3):940–945. doi: 10.1073/pnas.262787199 PubMedPubMedCentralCrossRefGoogle Scholar
  8. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H (2002) Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109(7):915–921. doi: 10.1172/JCI14588 PubMedPubMedCentralCrossRefGoogle Scholar
  9. Bedoui S, Miyake S, Straub RH, von Horsten S, Yamamura T (2004) More sympathy for autoimmunity with neuropeptide Y? Trends Immunol 25(10):508–512. doi: 10.1016/j.it.2004.08.005 PubMedCrossRefGoogle Scholar
  10. Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC (1996) Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 383(6600):525–528. doi: 10.1038/383525a0 PubMedCrossRefGoogle Scholar
  11. Benneker LM, Andersson G, Iatridis JC, Sakai D, Hartl R, Ito K, Grad S (2014) Cell therapy for intervertebral disc repair: advancing cell therapy from bench to clinics. Eur Cell Mater 27:5–11PubMedPubMedCentralCrossRefGoogle Scholar
  12. Besedovsky HO, del Rey A (1996) Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17(1):64–102PubMedCrossRefGoogle Scholar
  13. Binch AL, Cole AA, Breakwell LM, Michael AL, Chiverton N, Cross AK, Le Maitre CL (2014) Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration. Arthritis Res Ther 16(5):416. doi: 10.1186/s13075-014-0416-1 PubMedCrossRefGoogle Scholar
  14. Binch AL, Cole AA, Breakwell LM, Michael AL, Chiverton N, Creemers LB, Cross AK, Le Maitre CL (2015) Nerves are more abundant than blood vessels in the degenerate human intervertebral disc. Arthritis Res Ther 17(1):370. doi: 10.1186/s13075-015-0889-6 PubMedPubMedCentralCrossRefGoogle Scholar
  15. Bjurholm A, Kreicbergs A, Dahlberg L, Schultzberg M (1990) The occurrence of neuropeptides at different stages of DBM-induced heterotopic bone formation. Bone Miner 10(2):95–107PubMedCrossRefGoogle Scholar
  16. Bonini S, Rasi G, Bracci-Laudiero ML, Procoli A, Aloe L (2003) Nerve growth factor: neurotrophin or cytokine? Int Arch Allergy Immunol 131(2):80–84, doi:70922PubMedCrossRefGoogle Scholar
  17. Botelho M, Cavadas C (2015) Neuropeptide Y: an anti-aging player? Trends Neurosci 38(11):701–711. doi: 10.1016/j.tins.2015.08.012 PubMedCrossRefGoogle Scholar
  18. Braun HJ, Busfield BT, Kim HJ, Scuderi GJ, Dragoo JL (2013) The effect of local anaesthetics on synoviocytes: a possible indirect mechanism of chondrolysis. Knee Surg Sports Traumatol Arthrosc Official J ESSKA 21(6):1468–1474. doi: 10.1007/s00167-012-2104-5 CrossRefGoogle Scholar
  19. Buma P, Verschuren C, Versleyen D, Van der KP, Oestreicher AB (1992) Calcitonin gene-related peptide, substance P and GAP-43/B-50 immunoreactivity in the normal and arthrotic knee joint of the mouse. Histochemistry 98(5):327–339PubMedCrossRefGoogle Scholar
  20. Capellino S, Cosentino M, Wolff C, Schmidt M, Grifka J, Straub RH (2010) Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target. Ann Rheum Dis 69(10):1853–1860. doi: 10.1136/ard.2009.119701, ard.2009.119701 [pii]PubMedCrossRefGoogle Scholar
  21. Capellino S, Weber K, Gelder M, Harle P, Straub RH (2012) First appearance and location of catecholaminergic cells during experimental arthritis and elimination by chemical sympathectomy. Arthritis Rheum 64(4):1110–1118. doi: 10.1002/art.33431 PubMedCrossRefGoogle Scholar
  22. Capellino S, Cosentino M, Luini A, Bombelli R, Lowin T, Cutolo M, Marino F, Straub RH (2014) Increased expression of dopamine receptors in synovial fibroblasts from patients with rheumatoid arthritis: inhibitory effects of dopamine on interleukin-8 and interleukin-6. Arthritis Rheumatol 66(10):2685–2693. doi: 10.1002/art.38746 PubMedCrossRefGoogle Scholar
  23. Carroll SH, Ravid K (2013) Differentiation of mesenchymal stem cells to osteoblasts and chondrocytes: a focus on adenosine receptors. Expert Rev Mol Med 15:e1. doi: 10.1017/erm.2013.2 PubMedCrossRefGoogle Scholar
  24. Chambers MG, Jasani MK, Bitensky L, Chayen J (1992) Chondrocytic monoamine oxidase activity in the development of natural murine osteoarthritis. Int J Exp Pathol 73(2):115–123PubMedPubMedCentralGoogle Scholar
  25. Chen Y, Michaelis M, Janig W, Devor M (1996) Adrenoreceptor subtype mediating sympathetic-sensory coupling in injured sensory neurons. J Neurophysiol 76(6):3721–3730PubMedGoogle Scholar
  26. Chubinskaya S, Kawakami M, Rappoport L, Matsumoto T, Migita N, Rueger DC (2007) Anti-catabolic effect of OP-1 in chronically compressed intervertebral discs. J Orthop Res Off Publ Orthop Res Soc 25(4):517–530. doi: 10.1002/jor.20339 CrossRefGoogle Scholar
  27. Cortes A, Gracia E, Moreno E, Mallol J, Lluis C, Canela EI, Casado V (2015) Moonlighting adenosine deaminase: a target protein for drug development. Med Res Rev 35(1):85–125. doi: 10.1002/med.21324 PubMedCrossRefGoogle Scholar
  28. Dayer JM, Burger D (2004) Cell-cell interactions and tissue damage in rheumatoid arthritis. Autoimmun Rev 3(Suppl 1):S14–S16PubMedGoogle Scholar
  29. Del Rey A, Wolff C, Wildmann J, Randolf A, Straub RH, Besedovsky HO (2010) When immune-neuro-endocrine interactions are disrupted: experimentally induced arthritis as an example. Neuroimmunomodulation 17(3):165–168. doi: 10.1159/000258714 PubMedCrossRefGoogle Scholar
  30. Delgado M, Abad C, Martinez C, Leceta J, Gomariz RP (2001) Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med 7(5):563–568. doi: 10.1038/87887 PubMedCrossRefGoogle Scholar
  31. Dimitrijevic M, Stanojevic S, Mitic K, Kustrimovic N, Vujic V, Miletic T, Kovacevic-Jovanovic V (2008) The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age. Peptides 29(12):2179–2187. doi: 10.1016/j.peptides.2008.08.017 PubMedCrossRefGoogle Scholar
  32. Dirmeier M, Capellino S, Schubert T, Angele P, Anders S, Straub RH (2008) Lower density of synovial nerve fibres positive for calcitonin gene-related peptide relative to substance P in rheumatoid arthritis but not in osteoarthritis. Rheumatology (Oxford) 47(1):36–40. doi: 10.1093/rheumatology/kem301, doi:47/1/36 [pii]CrossRefGoogle Scholar
  33. Dodge GR, Poole AR (1989) Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest 83(2):647–661. doi: 10.1172/JCI113929 PubMedPubMedCentralCrossRefGoogle Scholar
  34. Dodge GR, Pidoux I, Poole AR (1991) The degradation of type II collagen in rheumatoid arthritis: an immunoelectron microscopic study. Matrix 11(5):330–338PubMedCrossRefGoogle Scholar
  35. Dong T, Chang H, Zhang F, Chen W, Zhu Y, Wu T, Zhang Y (2015) Calcitonin gene-related peptide can be selected as a predictive biomarker on progression and prognosis of knee osteoarthritis. Int Orthop 39(6):1237–1243. doi: 10.1007/s00264-015-2744-4 PubMedCrossRefGoogle Scholar
  36. Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, Evans DJ, Haughton L, Bayram Z, Boyer S, Thomson B, Wolfe MS, Archer CW (2004) The surface of articular cartilage contains a progenitor cell population. J Cell Sci 117(Pt 6):889–897PubMedCrossRefGoogle Scholar
  37. Dygai AM, Khmelevskaya ES, Skurikhin EG, Pershina OV, Andreeva TV, Ermakova NN (2012) Catecholamine regulation of stromal precursors and hemopoietic stem cells in cytostatic myelosuppression. Bull Exp Biol Med 152(6):723–727PubMedCrossRefGoogle Scholar
  38. Edgar MA (2007) The nerve supply of the lumbar intervertebral disc. J Bone Joint Surg (Br) 89(9):1135–1139. doi: 10.1302/0301-620X.89B9.18939 CrossRefGoogle Scholar
  39. Edoff K, Hildebrand C (2003) Neuropeptide effects on rat chondrocytes and perichondrial cells in vitro. Neuropeptides 37(5):316–318PubMedCrossRefGoogle Scholar
  40. Edoff K, Grenegard M, Hildebrand C (2000) Retrograde tracing and neuropeptide immunohistochemistry of sensory neurones projecting to the cartilaginous distal femoral epiphysis of young rats. Cell Tissue Res 299(2):193–200PubMedCrossRefGoogle Scholar
  41. Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA, Ogawa Y, Liu X, Ware SM, Craigen WJ, Robert JJ, Vinson C, Nakao K, Capeau J, Karsenty G (2004) Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A. 2004;101(9):3258–63. Epub 2004 Feb 20. Google Scholar
  42. Elefteriou F (2005) Neuronal signaling and the regulation of bone remodeling. Cell Mol Life Sci CMLS 62(19–20):2339–2349. doi: 10.1007/s00018-005-5175-3 PubMedCrossRefGoogle Scholar
  43. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434(7032):514–520PubMedCrossRefGoogle Scholar
  44. Elefteriou F, Campbell P, Ma Y (2014) Control of bone remodeling by the peripheral sympathetic nervous system. Calcif Tissue Int 94(1):140–151. doi: 10.1007/s00223-013-9752-4 PubMedCrossRefGoogle Scholar
  45. Fassold A, Falk W, Anders S, Hirsch T, Mirsky VM, Straub RH (2009) Soluble neuropilin-2, a nerve repellent receptor, is increased in rheumatoid arthritis synovium and aggravates sympathetic fiber repulsion and arthritis. Arthritis Rheum 60(10):2892–2901. doi: 10.1002/art.24860 PubMedCrossRefGoogle Scholar
  46. Ferrell WR, Khoshbaten A (1989) Adrenoceptor profile of blood vessels in the knee joint of the rabbit. J Physiol 414:377–383PubMedPubMedCentralCrossRefGoogle Scholar
  47. Ferrell WR, Khoshbaten A (1990) Responses of blood vessels in the rabbit knee to electrical stimulation of the joint capsule. J Physiol 423:569–578PubMedPubMedCentralCrossRefGoogle Scholar
  48. Fickert S, Fiedler J, Brenner RE (2004) Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res Ther 6(5):R422–R432. doi: 10.1186/ar1210 PubMedPubMedCentralCrossRefGoogle Scholar
  49. Fortier LA, Nixon AJ (1997) Distributional changes in substance P nociceptive fiber patterns in naturally osteoarthritic articulations. J Rheumatol 24(3):524–530PubMedGoogle Scholar
  50. Freemont AJ, Watkins A, Le Maitre C, Baird P, Jeziorska M, Knight MT, Ross ER, O’Brien JP, Hoyland JA (2002) Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol 197(3):286–292. doi: 10.1002/path.1108 PubMedCrossRefGoogle Scholar
  51. Gajda M, Adriaensen D, Cichocki T (2000) Development of the innervation of long bones: expression of the growth-associated protein 43. Folia Histochem Cytobiol 38(3):103–110PubMedGoogle Scholar
  52. Garcia-Cosamalon J, del Valle ME, Calavia MG, Garcia-Suarez O, Lopez-Muniz A, Otero J, Vega JA (2010) Intervertebral disc, sensory nerves and neurotrophins: who is who in discogenic pain? J Anat 217(1):1–15. doi: 10.1111/j.1469-7580.2010.01227.x PubMedPubMedCentralCrossRefGoogle Scholar
  53. Goldring MB, Tsuchimochi K, Ijiri K (2006) The control of chondrogenesis. J Cell Biochem 97(1):33–44PubMedCrossRefGoogle Scholar
  54. Gomez C, Burt-Pichat B, Mallein-Gerin F, Merle B, Delmas PD, Skerry TM, Vico L, Malaval L, Chenu C (2005) Expression of semaphorin-3A and its receptors in endochondral ossification: potential role in skeletal development and innervation. Dev Dyn Off Publ Am Assoc Anat 234(2):393–403. doi: 10.1002/dvdy.20512 Google Scholar
  55. Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M (2006) Vasoactive intestinal peptide induces CD4+, CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis. Arthritis Rheum 54(3):864–876. doi: 10.1002/art.21652 PubMedCrossRefGoogle Scholar
  56. Goto T, Nakao K, Gunjigake KK, Kido MA, Kobayashi S, Tanaka T (2007) Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors. Neuropeptides 41(1):25–31PubMedCrossRefGoogle Scholar
  57. Grassel SG (2014) The role of peripheral nerve fibers and their neurotransmitters in cartilage and bone physiology and pathophysiology. Arthritis Res Ther 16(6):485PubMedPubMedCentralCrossRefGoogle Scholar
  58. Grogan SP, Miyaki S, Asahara H, D’Lima DD, Lotz MK (2009) Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthritis Res Ther 11(3):R85PubMedPubMedCentralCrossRefGoogle Scholar
  59. Gronblad M, Konttinen YT, Korkala O, Liesi P, Hukkanen M, Polak JM (1988) Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 15(12):1807–1810PubMedGoogle Scholar
  60. Gruber HE, Ingram JA, Hoelscher G, Zinchenko N, Norton HJ, Hanley EN Jr (2008) Brain-derived neurotrophic factor and its receptor in the human and the sand rat intervertebral disc. Arthritis Res Ther 10(4):R82. doi: 10.1186/ar2456 PubMedPubMedCentralCrossRefGoogle Scholar
  61. Hara-Irie F, Amizuka N, Ozawa H (1996) Immunohistochemical and ultrastructural localization of CGRP-positive nerve fibers at the epiphyseal trabecules facing the growth plate of rat femurs. Bone 18(1):29–39PubMedCrossRefGoogle Scholar
  62. Harle P, Mobius D, Carr DJ, Scholmerich J, Straub RH (2005) An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum 52(4):1305–1313PubMedCrossRefGoogle Scholar
  63. Harle P, Straub RH, Wiest R, Mayer A, Scholmerich J, Atzeni F, Carrabba M, Cutolo M, Sarzi-Puttini P (2006) Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Ann Rheum Dis 65(1):51–56. doi: 10.1136/ard.2005.038059 PubMedCrossRefGoogle Scholar
  64. Hartung HP, Toyka KV (1983) Activation of macrophages by substance P: induction of oxidative burst and thromboxane release. Eur J Pharmacol 89(3–4):301–305PubMedCrossRefGoogle Scholar
  65. Hinck L (2004) The versatile roles of “axon guidance” cues in tissue morphogenesis. Dev Cell 7(6):783–793. doi: 10.1016/j.devcel.2004.11.002 PubMedCrossRefGoogle Scholar
  66. Holmes G, Niswander L (2001) Expression of slit-2 and slit-3 during chick development. Dev Dyn Off Publ Am Assoc Anat 222(2):301–307. doi: 10.1002/dvdy.1182 Google Scholar
  67. Howard MR, Millward-Sadler SJ, Vasilliou AS, Salter DM, Quinn JP (2008) Mechanical stimulation induces preprotachykinin gene expression in osteoarthritic chondrocytes which is correlated with modulation of the transcription factor neuron restrictive silence factor. Neuropeptides 42(5–6):681–686. doi: 10.1016/j.npep.2008.09.004 PubMedCrossRefGoogle Scholar
  68. Hukkanen M, Konttinen YT, Rees RG, Santavirta S, Terenghi G, Polak JM (1992) Distribution of nerve endings and sensory neuropeptides in rat synovium, meniscus and bone. Int J Tissue React 14(1):1–10PubMedGoogle Scholar
  69. Im HJ, Li X, Muddasani P, Kim GH, Davis F, Rangan J, Forsyth CB, Ellman M, Thonar EJ (2008) Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes. J Cell Physiol 215(2):452–463PubMedPubMedCentralCrossRefGoogle Scholar
  70. Imai S, Tokunaga Y, Konttinen YT, Maeda T, Hukuda S, Santavirta S (1997) Ultrastructure of the synovial sensory peptidergic fibers is distinctively altered in different phases of adjuvant induced arthritis in rats: ultramorphological characterization combined with morphometric and immunohistochemical study for substance P, calcitonin gene related peptide, and protein gene product 9.5. J Rheumatol 24(11):2177–2187PubMedGoogle Scholar
  71. Inoue H, Shimoyama Y, Hirabayashi K, Kajigaya H, Yamamoto S, Oda H, Koshihara Y (2001) Production of neuropeptide substance P by synovial fibroblasts from patients with rheumatoid arthritis and osteoarthritis. Neurosci Lett 303(3):149–152PubMedCrossRefGoogle Scholar
  72. Jenei-Lanzl Z, Grassel S, Pongratz G, Kees F, Miosge N, Angele P, Straub RH (2014) Norepinephrine inhibits mesenchymal stem cell and chondrogenic progenitor cell chondrogenesis and accelerates chondrogenic hypertrophy. Arthritis Rheumatol. doi: 10.1002/art.38695 PubMedGoogle Scholar
  73. Jenei-Lanzl Z, Capellino S, Kees F, Fleck M, Lowin T, Straub RH (2015a) Anti-inflammatory effects of cell-based therapy with tyrosine hydroxylase-positive catecholaminergic cells in experimental arthritis. Ann Rheum Dis 74(2):444–451. doi: 10.1136/annrheumdis-2013-203925 PubMedCrossRefGoogle Scholar
  74. Jenei-Lanzl Z, Zwingenberg J, Lowin T, Anders S, Straub RH (2015b) Proinflammatory receptor switch from galphas to galphai signaling by beta-arrestin-mediated PDE4 recruitment in mixed RA synovial cells. Brain Behav Immun 50:266–274. doi: 10.1016/j.bbi.2015.07.020 PubMedCrossRefGoogle Scholar
  75. Jiang JL, Qiu YH, Peng YP, Wang JJ (2006) Immunoregulatory role of endogenous catecholamines synthesized by immune cells. Sheng Li Xue Bao 58(4):309–317PubMedGoogle Scholar
  76. Jiao K, Niu L, Xu X, Liu Y, Li X, Tay FR, Wang M (2015) Norepinephrine regulates condylar bone loss via comorbid factors. J Dent Res 94(6):813–820. doi: 10.1177/0022034515577677 PubMedCrossRefGoogle Scholar
  77. Jikko A, Murakami H, Yan W, Nakashima K, Ohya Y, Satakeda H, Noshiro M, Kawamoto T, Nakamura S, Okada Y, Suzuki F, Kato Y (1996) Effects of cyclic adenosine 3′,5′-monophosphate on chondrocyte terminal differentiation and cartilage-matrix calcification. Endocrinology 137(1):122–128. doi: 10.1210/endo.137.1.8536602 PubMedGoogle Scholar
  78. Johnson WE, Sivan S, Wright KT, Eisenstein SM, Maroudas A, Roberts S (2006) Human intervertebral disc cells promote nerve growth over substrata of human intervertebral disc aggrecan. Spine (Phila Pa 1976) 31(11):1187–1193. doi: 10.1097/01.brs.0000217669.04903.61 CrossRefGoogle Scholar
  79. Kane D, Jensen LE, Grehan S, Whitehead AS, Bresnihan B, Fitzgerald O (2004) Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction. J Rheumatol 31(7):1274–1280PubMedGoogle Scholar
  80. Karahan S, Kincaid SA, Baird AN, Kammermann JR (2002) Distribution of beta-endorphin and substance P in the shoulder joint of the dog before and after a low impact exercise programme. Anat Histol Embryol 31(2):72–77PubMedCrossRefGoogle Scholar
  81. Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, Frenette PS (2006) Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124(2):407–421. doi: 10.1016/j.cell.2005.10.041 PubMedCrossRefGoogle Scholar
  82. Kepler CK, Markova DZ, Hilibrand AS, Vaccaro AR, Risbud MV, Albert TJ, Anderson DG (2013) Substance P stimulates production of inflammatory cytokines in human disc cells. Spine (Phila Pa 1976) 38(21):E1291–E1299. doi: 10.1097/BRS.0b013e3182a42bc2 CrossRefGoogle Scholar
  83. Kepler CK, Markova DZ, Koerner JD, Mendelis J, Chen CM, Vaccaro AR, Risbud MV, Albert TJ, Anderson DG (2015) Substance P receptor antagonist suppresses inflammatory cytokine expression in human disc cells. Spine (Phila Pa 1976) 40(16):1261–1269. doi: 10.1097/BRS.0000000000000954 CrossRefGoogle Scholar
  84. Keyszer G, Langer T, Kornhuber M, Taute B, Horneff G (2004) Neurovascular mechanisms as a possible cause of remission of rheumatoid arthritis in hemiparetic limbs. Ann Rheum Dis 63(10):1349–1351. doi: 10.1136/ard.2003.016410 PubMedPubMedCentralCrossRefGoogle Scholar
  85. Kimberly CL, Byers MR (1988) Inflammation of rat molar pulp and periodontium causes increased calcitonin gene-related peptide and axonal sprouting. Anat Rec 222(3):289–300. doi: 10.1002/ar.1092220310 PubMedCrossRefGoogle Scholar
  86. Kitsukawa T, Shimono A, Kawakami A, Kondoh H, Fujisawa H (1995) Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121(12):4309–4318PubMedGoogle Scholar
  87. Knedla A, Neumann E, Muller-Ladner U (2007) Developments in the synovial biology field 2006. Arthritis Res Ther 9(2):209. doi: 10.1186/ar2140 PubMedPubMedCentralCrossRefGoogle Scholar
  88. Koeck FX, Bobrik V, Fassold A, Grifka J, Kessler S, Straub RH (2009) Marked loss of sympathetic nerve fibers in chronic Charcot foot of diabetic origin compared to ankle joint osteoarthritis. J Orthop Res 27(6):736–741. doi: 10.1002/jor.20807 PubMedCrossRefGoogle Scholar
  89. Kondo M, Yamaoka K, Tanaka Y (2014) Acquiring chondrocyte phenotype from human mesenchymal stem cells under inflammatory conditions. Int J Mol Sci 15(11):21270–21285. doi: 10.3390/ijms151121270 PubMedPubMedCentralCrossRefGoogle Scholar
  90. Koolpe M, Pearson D, Benton HP (1999) Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release. Arthritis Rheum 42(2):258–267. doi: 10.1002/1529-0131(199902)42:2<258::AID-ANR7>3.0.CO;2-O PubMedCrossRefGoogle Scholar
  91. Lai LP, Mitchell J (2008) Beta2-adrenergic receptors expressed on murine chondrocytes stimulate cellular growth and inhibit the expression of Indian hedgehog and collagen type X. J Cell Biochem 104(2):545–553PubMedCrossRefGoogle Scholar
  92. Larsson J, Ekblom A, Henriksson K, Lundeberg T, Theodorsson E (1991) Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand J Rheumatol 20(5):326–335PubMedCrossRefGoogle Scholar
  93. Lee S, Moon CS, Sul D, Lee J, Bae M, Hong Y, Lee M, Choi S, Derby R, Kim BJ, Kim J, Yoon JS, Wolfer L, Kim J, Wang J, Hwang SW, Lee SH (2009) Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus. Clin Biochem 42(15):1504–1511. doi: 10.1016/j.clinbiochem.2009.06.017 PubMedCrossRefGoogle Scholar
  94. Lerner UH, Persson E (2008) Osteotropic effects by the neuropeptides calcitonin gene-related peptide, substance P and vasoactive intestinal peptide. J Musculoskelet Neuronal Interact 8(2):154–165PubMedGoogle Scholar
  95. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A (1996) Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 19(11):514–520. doi: 10.1016/S0166-2236(96)10058-8 PubMedCrossRefGoogle Scholar
  96. Levine JD, Goetzl EJ, Basbaum AI (1987) Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. Rheum Dis Clin N Am 13(2):369–383Google Scholar
  97. Li W, Long X, Jiang S, Li Y, Fang W (2015) Histamine and substance P in synovial fluid of patients with temporomandibular disorders. J Oral Rehabil 42(5):363–369. doi: 10.1111/joor.12265 PubMedCrossRefGoogle Scholar
  98. Loeser RF (2003) Systemic and local regulation of articular cartilage metabolism: where does leptin fit in the puzzle? Arthritis Rheum 48(11):3009–3012. doi: 10.1002/art.11315 PubMedCrossRefGoogle Scholar
  99. Lorenz J, Schafer N, Bauer R, Jenei-Lanzl Z, Springorum RH, Grassel S (2016) Norepinephrine modulates osteoarthritic chondrocyte metabolism and inflammatory responses. Osteoarthr Cartil OARS Osteoarthr Res Soc 24(2):325–334. doi: 10.1016/j.joca.2015.08.007 CrossRefGoogle Scholar
  100. Lorton D, Bellinger DL, Schaller JA, Shewmaker E, Osredkar T, Lubahn C (2013) Altered sympathetic-to-immune cell signaling via beta(2)-adrenergic receptors in adjuvant arthritis. Clin Dev Immunol 2013:764395. doi: 10.1155/2013/764395 PubMedPubMedCentralCrossRefGoogle Scholar
  101. Lotz M, Carson DA, Vaughan JH (1987) Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235(4791):893–895PubMedCrossRefGoogle Scholar
  102. Lotz M, Vaughan JH, Carson DA (1988) Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241(4870):1218–1221PubMedCrossRefGoogle Scholar
  103. Lubahn CL, Schaller JA, Bellinger DL, Sweeney S, Lorton D (2004) The importance of timing of adrenergic drug delivery in relation to the induction and onset of adjuvant-induced arthritis. Brain Behav Immun 18(6):563–571. doi: 10.1016/j.bbi.2004.02.004 PubMedCrossRefGoogle Scholar
  104. Lundberg P, Allison SJ, Lee NJ, Baldock PA, Brouard N, Rost S, Enriquez RF, Sainsbury A, Lamghari M, Simmons P, Eisman JA, Gardiner EM, Herzog H (2007) Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem 282(26):19082–19091. doi: 10.1074/jbc.M609629200 PubMedCrossRefGoogle Scholar
  105. Madsen JE, Hukkanen M, Aune AK, Basran I, Moller JF, Polak JM, Nordsletten L (1998) Fracture healing and callus innervation after peripheral nerve resection in rats. Clin Orthop Relat Res 351:230–240CrossRefGoogle Scholar
  106. Maestroni GJ (2000) Neurohormones and catecholamines as functional components of the bone marrow microenvironment. Ann N Y Acad Sci 917:29–37PubMedCrossRefGoogle Scholar
  107. Maestroni GJ, Cosentino M, Marino F, Togni M, Conti A, Lecchini S, Frigo G (1998) Neural and endogenous catecholamines in the bone marrow. Circadian association of norepinephrine with hematopoiesis? Exp Hematol 26(12):1172–1177PubMedGoogle Scholar
  108. Maggi CA (1995) The mammalian tachykinin receptors. Gen Pharmacol 26(5):911–944PubMedCrossRefGoogle Scholar
  109. Malmberg AB, Chen C, Tonegawa S, Basbaum AI (1997) Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science 278(5336):279–283PubMedCrossRefGoogle Scholar
  110. Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, Daughters RS, Lappi DA, Wiley RG, Simone DA (1997) Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science 278(5336):275–279PubMedCrossRefGoogle Scholar
  111. Mapp PI, Avery PS, McWilliams DF, Bowyer J, Day C, Moores S, Webster R, Walsh DA (2008) Angiogenesis in two animal models of osteoarthritis. Osteoarthritis Cartilage 16(1):61–9. Epub 2007 Jul 30.Google Scholar
  112. Mapp PI, Kidd BL, Gibson SJ, Terry JM, Revell PA, Ibrahim NB, Blake DR, Polak JM (1990) Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 37(1):143–153PubMedCrossRefGoogle Scholar
  113. Mapp PI, Walsh DA (2012) Mechanisms and targets of angiogenesis and nerve growth in osteo-arthritis. Nat Rev Rheumatol 8(7):390–8. doi: 10.1038/nrrheum.2012.80. Review.
  114. Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, Anand P (2004) Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 16(9):897–902PubMedCrossRefGoogle Scholar
  115. Mauro LJ, Wenzel SJ, Sindberg GM (2010) Regulation of chick bone growth by leptin and catecholamines. Poult Sci 89(4):697–708PubMedCrossRefGoogle Scholar
  116. Mediero A, Cronstein BN (2013) Adenosine and bone metabolism. Trends Endocrinol Metab 24(6):290–300. doi: 10.1016/j.tem.2013.02.001 PubMedPubMedCentralCrossRefGoogle Scholar
  117. Meyer LH, Franssen L, Pap T (2006) The role of mesenchymal cells in the pathophysiology of inflammatory arthritis. Best Pract Res Clin Rheumatol 20(5):969–981. doi: 10.1016/j.berh.2006.06.005 PubMedCrossRefGoogle Scholar
  118. Mignini F, Streccioni V, Amenta F (2003) Autonomic innervation of immune organs and neuroimmune modulation. Auton Autacoid Pharmacol 23(1):1–25PubMedCrossRefGoogle Scholar
  119. Miller LE, Justen HP, Scholmerich J, Straub RH (2000) The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 14(13):2097–2107PubMedCrossRefGoogle Scholar
  120. Miller LE, Grifka J, Scholmerich J, Straub RH (2002) Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis. J Rheumatol 29(3):427–435PubMedGoogle Scholar
  121. Miller LE, Weidler C, Falk W, Angele P, Schaumburger J, Scholmerich J, Straub RH (2004) Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 50(4):1156–1163. doi: 10.1002/art.20110 PubMedCrossRefGoogle Scholar
  122. Millward-Sadler SJ, Wright MO, Davies LW, Nuki G, Salter DM (2000) Mechanotransduction via integrins and interleukin-4 results in altered aggrecan and matrix metalloproteinase 3 gene expression in normal, but not osteoarthritic, human articular chondrocytes. Arthritis Rheum 43(9):2091–2099. doi: 10.1002/1529-0131(200009)43:9<2091::AID-ANR21>3.0.CO;2-C PubMedCrossRefGoogle Scholar
  123. Millward-Sadler SJ, Mackenzie A, Wright MO, Lee HS, Elliot K, Gerrard L, Fiskerstrand CE, Salter DM, Quinn JP (2003) Tachykinin expression in cartilage and function in human articular chondrocyte mechanotransduction. Arthritis Rheum 48(1):146–156PubMedCrossRefGoogle Scholar
  124. Mistry D, Chambers MG, Mason RM (2006) The role of adenosine in chondrocyte death in murine osteoarthritis and in a murine chondrocyte cell line. Osteoarthr Cartil OARS Osteoarthr Res Soc 14(5):486–495. doi: 10.1016/j.joca.2005.11.015 CrossRefGoogle Scholar
  125. Mitchell NS, Shepard N (1978) Changes in proteoglycan and collagen in cartilage in rheumatoid arthritis. J Bone Joint Surg Am 60(3):342–348PubMedCrossRefGoogle Scholar
  126. Mitchell J, Lai LP, Peralta F, Xu Y, Sugamori K (2011) Beta2-adrenergic receptors inhibit the expression of collagen type II in growth plate chondrocytes by stimulating the AP-1 factor Jun-B. Am J Physiol Endocrinol Metab 300(4):E633–E639PubMedCrossRefGoogle Scholar
  127. Molinoff PB (1984) Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation. Drugs 28(Suppl 2):1–15PubMedCrossRefGoogle Scholar
  128. Murakami K, Nakagawa H, Nishimura K, Matsuo S (2015) Changes in peptidergic fiber density in the synovium of mice with collagenase-induced acute arthritis. Can J Physiol Pharmacol 93(6):435–441. doi: 10.1139/cjpp-2014-0446 PubMedCrossRefGoogle Scholar
  129. Muschter D, Gottl C, Vogel M, Grifka J, Straub RH, Grassel S (2015a) Reactivity of rat bone marrow-derived macrophages to neurotransmitter stimulation in the context of collagen II-induced arthritis. Arthritis Res Ther 17(1):169. doi: 10.1186/s13075-015-0684-4 PubMedPubMedCentralCrossRefGoogle Scholar
  130. Muschter D, Schafer N, Stangl H, Straub RH, Grassel S (2015b) Sympathetic neurotransmitters modulate osteoclastogenesis and osteoclast activity in the context of collagen-induced arthritis. PLoS ONE 10(10):e0139726. doi: 10.1371/journal.pone.0139726 PubMedPubMedCentralCrossRefGoogle Scholar
  131. Nakasa T, Ishikawa M, Takada T, Miyaki S, Ochi M (2015) Attenuation of cartilage degeneration by calcitonin gene-related paptide receptor antagonist via inhibition of subchondral bone sclerosis in osteoarthritis mice. J Orthop Res Off Publ Orthop Res Soc. doi: 10.1002/jor.23132 Google Scholar
  132. Napolitano A, Cesura AM, Da Prada M (1995) The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission. J Neural Transm Suppl 45:35–45PubMedGoogle Scholar
  133. Naukkarinen A, Nickoloff BJ, Farber EM (1989) Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 92(1):126–129PubMedCrossRefGoogle Scholar
  134. Niissalo S, Hukkanen M, Imai S, Tornwall J, Konttinen YT (2002) Neuropeptides in experimental and degenerative arthritis. Ann N Y Acad Sci 966:384–399PubMedCrossRefGoogle Scholar
  135. O’Sullivan J, D’Arcy S, Barry FP, Murphy JM, Coleman CM (2011) Mesenchymal chondroprogenitor cell origin and therapeutic potential. Stem Cell Res Ther 2(1):8. doi: 10.1186/scrt49 PubMedPubMedCentralCrossRefGoogle Scholar
  136. Ohtori S, Inoue G, Koshi T, Ito T, Doya H, Moriya H, Takahashi K (2006) Substance P-saporin down-regulates substance P receptor immunoreactive sensory dorsal root ganglion neurons innervating the lumbar intervertebral discs in rats. Spine (Phila Pa 1976) 31(26):2987–2991. doi: 10.1097/01.brs.0000250306.12996.fa CrossRefGoogle Scholar
  137. Okubo M, Kimura T, Fujita Y, Mochizuki S, Niki Y, Enomoto H, Suda Y, Toyama Y, Okada Y (2011) Semaphorin 3A is expressed in human osteoarthritic cartilage and antagonizes vascular endothelial growth factor 165-promoted chondrocyte migration: an implication for chondrocyte cloning. Arthritis Rheum 63(10):3000–3009. doi: 10.1002/art.30482 PubMedCrossRefGoogle Scholar
  138. Oliva F, Tarantino U, Maffulli N (2005) Immunohistochemical localization of calcitonin gene-related peptide and substance P in the rat knee cartilage at birth. Physiol Res 54(5):549–556PubMedGoogle Scholar
  139. Opolka A, Straub RH, Pasoldt A, Grifka J, Grassel S (2012) Substance P and norepinephrine modulate murine chondrocyte proliferation and apoptosis. Arthritis Rheum 64(3):729–739PubMedCrossRefGoogle Scholar
  140. Otero M, Goldring MB (2007) Cells of the synovium in rheumatoid arthritis. Chondrocytes. Arthritis Res Ther 9(5):220. doi: 10.1186/ar2292 PubMedPubMedCentralCrossRefGoogle Scholar
  141. Otero M, Lago R, Gomez R, Dieguez C, Lago F, Gomez-Reino J, Gualillo O (2006) Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 45(8):944–950CrossRefGoogle Scholar
  142. Pongratz G, Straub RH (2013) Role of peripheral nerve fibres in acute and chronic inflammation in arthritis. Nat Rev Rheumatol 9(2):117–126. doi: 10.1038/nrrheum.2012.181 PubMedCrossRefGoogle Scholar
  143. Pongratz G, Straub RH (2014) The sympathetic nervous response in inflammation. Arthritis Res Ther 16(6):504PubMedPubMedCentralCrossRefGoogle Scholar
  144. Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW (2005) Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 64(8):1195–1198PubMedPubMedCentralCrossRefGoogle Scholar
  145. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54(2):233–246PubMedCrossRefGoogle Scholar
  146. Pretzel D, Linss S, Rochler S, Endres M, Kaps C, Alsalameh S, Kinne RW (2011) Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage. Arthritis Res Ther 13(2):R64. doi: 10.1186/ar3320 PubMedPubMedCentralCrossRefGoogle Scholar
  147. Purmessur D, Freemont AJ, Hoyland JA (2008) Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc. Arthritis Res Ther 10(4):R99. doi: 10.1186/ar2487 PubMedPubMedCentralCrossRefGoogle Scholar
  148. Raj PP (2008) Intervertebral disc: anatomy-physiology-pathophysiology-treatment. Pain Pract 8(1):18–44. doi: 10.1111/j.1533-2500.2007.00171.x PubMedCrossRefGoogle Scholar
  149. Rao AJ, Johnston TR, Harris AH, Smith RL, Costouros JG (2014) Inhibition of chondrocyte and synovial cell death after exposure to commonly used anesthetics: chondrocyte apoptosis after anesthetics. Am J Sports Med 42(1):50–58. doi: 10.1177/0363546513507426 PubMedCrossRefGoogle Scholar
  150. Ribatti D, Conconi MT, Nussdorfer GG (2007) Nonclassic endogenous novel [corrected] regulators of angiogenesis. Pharmacol Rev 59(2):185–205. doi: 10.1124/pr.59.2.3 PubMedCrossRefGoogle Scholar
  151. Richardson SM, Doyle P, Minogue BM, Gnanalingham K, Hoyland JA (2009) Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc. Arthritis Res Ther 11(4):R126. doi: 10.1186/ar2793 PubMedPubMedCentralCrossRefGoogle Scholar
  152. Roemer FW, Guermazi A, Felson DT, Niu J, Nevitt MC, Crema MD, Lynch JA, Lewis CE, Torner J, Zhang Y (2011) Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann Rheum Dis 70(10):1804–1809. doi: 10.1136/ard.2011.150243 PubMedPubMedCentralCrossRefGoogle Scholar
  153. Romio M, Reinbeck B, Bongardt S, Huls S, Burghoff S, Schrader J (2011) Extracellular purine metabolism and signaling of CD73-derived adenosine in murine treg and teff cells. Am J Physiol Cell Physiol 301(2):C530–C539. doi: 10.1152/ajpcell.00385.2010 PubMedCrossRefGoogle Scholar
  154. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304(5922):129–135PubMedCrossRefGoogle Scholar
  155. Ruff MR, Wahl SM, Pert CB (1985) Substance P receptor-mediated chemotaxis of human monocytes. Peptides 6(Suppl 2):107–111PubMedCrossRefGoogle Scholar
  156. Saba F, Soleimani M, Atashi A, Mortaz E, Shahjahani M, Roshandel E, Jaseb K, Saki N (2013) The role of the nervous system in hematopoietic stem cell mobilization. Lab Hematol 19(3):8–16. doi: 10.1532/LH96.12013 PubMedCrossRefGoogle Scholar
  157. Saito T (1992) Immunohistochemical study on the effect of high tibial osteotomy on the distribution pattern of neuropeptides in the synovium of the osteoarthritic knee. Nihon Seikeigeka Gakkai Zasshi 66(9):884–897PubMedGoogle Scholar
  158. Saito T, Koshino T (2000) Distribution of neuropeptides in synovium of the knee with osteoarthritis. Clin Orthop Relat Res 376:172–182CrossRefGoogle Scholar
  159. Salo PT, Seeratten RA, Erwin WM, Bray RC (2002) Evidence for a neuropathic contribution to the development of spontaneous knee osteoarthrosis in a mouse model. Acta Orthop Scand 73(1):77–84PubMedCrossRefGoogle Scholar
  160. Sanders VM, Straub RH (2002) Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav Immun 16(4):290–332PubMedCrossRefGoogle Scholar
  161. Sariola H (2001) The neurotrophic factors in non-neuronal tissues. Cell Mol Life Sci CMLS 58(8):1061–1066PubMedCrossRefGoogle Scholar
  162. Saxler G, Loer F, Skumavc M, Pfortner J, Hanesch U (2007) Localization of SP- and CGRP-immunopositive nerve fibers in the hip joint of patients with painful osteoarthritis and of patients with painless failed total hip arthroplasties. Eur J Pain 11(1):67–74. doi: 10.1016/j.ejpain.2005.12.011 PubMedCrossRefGoogle Scholar
  163. Schaible HG (2012) Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep 14(6):549–556. doi: 10.1007/s11926-012-0279-x PubMedCrossRefGoogle Scholar
  164. Schaible HG, Straub RH (2014) Function of the sympathetic supply in acute and chronic experimental joint inflammation. Auton Neurosci 182:55–64. doi: 10.1016/j.autneu.2013.12.004 PubMedCrossRefGoogle Scholar
  165. Schinke T, Liese S, Priemel M, Haberland M, Schilling AF, Catala-Lehnen P, Blicharski D, Rueger JM, Gagel RF, Emeson RB, Amling M (2004) Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide. J Bone Miner Res 19(12):2049–2056PubMedCrossRefGoogle Scholar
  166. Schubert T, Denk A, Magdefrau U, Kaufmann S, Bastone P, Lowin T, Schedel J, Bosserhoff AK (2009a) Role of the netrin system of repellent factors on synovial fibroblasts in rheumatoid arthritis and osteoarthritis. Int J Immunopathol Pharmacol 22(3):715–722PubMedCrossRefGoogle Scholar
  167. Schubert T, Kaufmann S, Wenke AK, Grassel S, Bosserhoff AK (2009b) Role of deleted in colon carcinoma in osteoarthritis and in chondrocyte migration. Rheumatology 48(11):1435–1441. doi: 10.1093/rheumatology/kep245 PubMedCrossRefGoogle Scholar
  168. Schwab W, Funk RH (1998) Innervation pattern of different cartilaginous tissues in the rat. Acta Anat (Basel) 163(4):184–190CrossRefGoogle Scholar
  169. Serafini T, Kennedy TE, Galko MJ, Mirzayan C, Jessell TM, Tessier-Lavigne M (1994) The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 78(3):409–424PubMedCrossRefGoogle Scholar
  170. Silva WA Jr, Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, Santos AR, Zago MA (2003) The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 21(6):661–669. doi: 10.1634/stemcells.21-6-661 PubMedCrossRefGoogle Scholar
  171. Simao AP, Mendonca VA, de Oliveira Almeida TM, Santos SA, Gomes WF, Coimbra CC, Lacerda AC (2014) Involvement of BDNF in knee osteoarthritis: the relationship with inflammation and clinical parameters. Rheumatol Int 34(8):1153–1157. doi: 10.1007/s00296-013-2943-5 PubMedGoogle Scholar
  172. Sipos G, Sipos P, Altdorfer K, Pongor E, Feher E (2008) Correlation and immunolocalization of substance P nerve fibers and activated immune cells in human chronic gastritis. Anat Rec (Hoboken) 291(9):1140–1148. doi: 10.1002/ar.20737 CrossRefGoogle Scholar
  173. Sitkovsky MV (2003) Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem Pharmacol 65(4):493–501PubMedCrossRefGoogle Scholar
  174. Smith CH, Barker JN, Morris RW, MacDonald DM, Lee TH (1993) Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 151(6):3274–3282PubMedGoogle Scholar
  175. Stangenberg L, Burzyn D, Binstadt BA, Weissleder R, Mahmood U, Benoist C, Mathis D (2014) Denervation protects limbs from inflammatory arthritis via an impact on the microvasculature. Proc Natl Acad Sci U S A 111(31):11419–11424. doi: 10.1073/pnas.1410854111 PubMedPubMedCentralCrossRefGoogle Scholar
  176. Stanojevic S, Dimitrijevic M, Kustrimovic N, Mitic K, Vujic V, Leposavic G (2013) Adrenal hormone deprivation affects macrophage catecholamine metabolism and beta2-adrenoceptor density, but not propranolol stimulation of tumour necrosis factor-alpha production. Exp Physiol 98(3):665–678. doi: 10.1113/expphysiol.2012.070524 PubMedCrossRefGoogle Scholar
  177. Steele PA, Gibbins IL, Morris JL (1996) Projections of intrinsic cardiac neurons to different targets in the guinea-pig heart. J Auton Nerv Syst 56(3):191–200PubMedCrossRefGoogle Scholar
  178. Stolk L, van Meurs JB, Jhamai M, Arp PP, van Leeuwen JP, Hofman A, de Jong FH, Pols HA, Uitterlinden AG (2007) The catechol-O-methyltransferase Met158 low-activity allele and association with nonvertebral fracture risk in elderly men. J Clin Endocrinol Metab 92(8):3206–3212. doi: 10.1210/jc.2006-2136 PubMedCrossRefGoogle Scholar
  179. Strange-Vognsen HH, Laursen H (1997) Nerves in human epiphyseal uncalcified cartilage. J Pediatr Orthop B 6(1):56–58PubMedCrossRefGoogle Scholar
  180. Straub RH (2015) The origin of chronic inflammatory systemic diseases and their sequelae. San Diego Elsevier-Academic PressGoogle Scholar
  181. Straub RH, Mayer M, Kreutz M, Leeb S, Scholmerich J, Falk W (2000) Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol 67(4):553–558PubMedGoogle Scholar
  182. Straub RH, Grum F, Strauch U, Capellino S, Bataille F, Bleich A, Falk W, Scholmerich J, Obermeier F (2008) Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation. Gut 57(7):911–921. doi: 10.1136/gut.2007.125401 PubMedCrossRefGoogle Scholar
  183. Straub RH, Bijlsma JW, Masi A, Cutolo M (2013) Role of neuroendocrine and neuroimmune mechanisms in chronic inflammatory rheumatic diseases – the 10-year update. Semin Arthritis Rheum 43(3):392–404. doi: 10.1016/j.semarthrit.2013.04.008 PubMedCrossRefGoogle Scholar
  184. Stucky CL, Lewin GR (1999) Isolectin B(4)-positive and -negative nociceptors are functionally distinct. J Neurosci Off J Soc Neurosci 19(15):6497–6505Google Scholar
  185. Sun Y, Huang J, Xiang Y, Bastepe M, Juppner H, Kobilka BK, Zhang JJ, Huang XY (2007) Dosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCR. EMBO J 26(1):53–64. doi: 10.1038/sj.emboj.7601502 PubMedCrossRefGoogle Scholar
  186. Suri S, Gill SE, Massena DC, Wilson D, McWilliams DF, Walsh DA (2007) Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis 66(11):1423–1428PubMedPubMedCentralCrossRefGoogle Scholar
  187. Takahashi Y, Ohtori S, Takahashi K (2009) Peripheral nerve pathways of afferent fibers innervating the lumbar spine in rats. J Pain 10(4):416–425. doi: 10.1016/j.jpain.2008.10.012 PubMedCrossRefGoogle Scholar
  188. Takahata Y, Takarada T, Iemata M, Yamamoto T, Nakamura Y, Kodama A, Yoneda Y (2009) Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells. J Cell Physiol 218(2):268–275PubMedCrossRefGoogle Scholar
  189. Takao T, Iwaki T, Kondo J, Hiraki Y (2000) Immunohistochemistry of chondromodulin-I in the human intervertebral discs with special reference to the degenerative changes. Histochem J 32(9):545–550PubMedCrossRefGoogle Scholar
  190. Takarada T, Hojo H, Iemata M, Sahara K, Kodama A, Nakamura N, Hinoi E, Yoneda Y (2009) Interference by adrenaline with chondrogenic differentiation through suppression of gene transactivation mediated by Sox9 family members. Bone 45(3):568–578PubMedCrossRefGoogle Scholar
  191. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111(3):305–17.Google Scholar
  192. Takebayashi T, Cavanaugh JM, Kallakuri S, Chen C, Yamashita T (2006) Sympathetic afferent units from lumbar intervertebral discs. J Bone Joint Surg (Br) 88(4):554–557. doi: 10.1302/0301-620X.88B4.17194 CrossRefGoogle Scholar
  193. Tanabe T, Otani H, Mishima K, Ogawa R, Inagaki C (1996) Mechanisms of oxyradical production in substance P stimulated rheumatoid synovial cells. Rheumatol Int 16(4):159–167PubMedCrossRefGoogle Scholar
  194. Tessarollo L (1998) Pleiotropic functions of neurotrophins in development. Cytokine Growth Factor Rev 9(2):125–137PubMedCrossRefGoogle Scholar
  195. Tolofari SK, Richardson SM, Freemont AJ, Hoyland JA (2010) Expression of semaphorin 3A and its receptors in the human intervertebral disc: potential role in regulating neural ingrowth in the degenerate intervertebral disc. Arthritis Res Ther 12(1):R1. doi: 10.1186/ar2898 PubMedPubMedCentralCrossRefGoogle Scholar
  196. Trzaska KA, King CC, Li KY, Kuzhikandathil EV, Nowycky MC, Ye JH, Rameshwar P (2009) Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons. J Neurochem 110(3):1058–1069. doi: 10.1111/j.1471-4159.2009.06201.x PubMedCrossRefGoogle Scholar
  197. Van Linden A, Eltzschig HK (2007) Role of pulmonary adenosine during hypoxia: extracellular generation, signaling and metabolism by surface adenosine deaminase/CD26. Expert Opin Biol Ther 7(9):1437–1447. doi: 10.1517/14712598.7.9.1437 PubMedCrossRefGoogle Scholar
  198. Vega JA, Garcia-Suarez O, Hannestad J, Perez-Perez M, Germana A (2003) Neurotrophins and the immune system. J Anat 203(1):1–19PubMedPubMedCentralCrossRefGoogle Scholar
  199. Vergroesen PP, Kingma I, Emanuel KS, Hoogendoorn RJ, Welting TJ, van Royen BJ, van Dieen JH, Smit TH (2015) Mechanics and biology in intervertebral disc degeneration: a vicious circle. Osteoarthr Cartil OARS Osteoarthr Res Soc 23(7):1057–1070. doi: 10.1016/j.joca.2015.03.028 CrossRefGoogle Scholar
  200. Vignon E, Broquet P, Mathieu P, Louisot P, Richard M (1990) Histaminergic H1, serotoninergic, beta adrenergic and dopaminergic receptors in human osteoarthritic cartilage. Biochem Int. 1990;20(2):251–5.Google Scholar
  201. Wada N, Tanaka H, Ide H, Nohno T (2003) Ephrin-A2 regulates position-specific cell affinity and is involved in cartilage morphogenesis in the chick limb bud. Dev Biol 264(2):550–563PubMedCrossRefGoogle Scholar
  202. Walsh DA, McWilliams DF, Turley MJ, Dixon MR, Franses RE, Mapp PI, Wilson D (2010) Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology 49(10):1852–1861. doi: 10.1093/rheumatology/keq188 PubMedPubMedCentralCrossRefGoogle Scholar
  203. Wang L, Zhang L, Pan H, Peng S, Lv M, Lu WW (2014) Levels of neuropeptide Y in synovial fluid relate to pain in patients with knee osteoarthritis. BMC Musculoskelet Disord 15:319. doi: 10.1186/1471-2474-15-319 PubMedPubMedCentralCrossRefGoogle Scholar
  204. Wang H, Zhang X, He JY, Zheng XF, Li D, Li Z, Zhu JF, Shen C, Cai GQ, Chen XD (2015) Increasing expression of substance P and calcitonin gene-related peptide in synovial tissue and fluid contribute to the progress of arthritis in developmental dysplasia of the hip. Arthritis Res Ther 17:4. doi: 10.1186/s13075-014-0513-1 PubMedPubMedCentralCrossRefGoogle Scholar
  205. Weidler C, Holzer C, Harbuz M, Hofbauer R, Angele P, Scholmerich J, Straub RH (2005) Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium. Ann Rheum Dis 64(1):13–20PubMedPubMedCentralCrossRefGoogle Scholar
  206. Wheway J, Herzog H, Mackay F (2007) NPY and receptors in immune and inflammatory diseases. Curr Top Med Chem 7(17):1743–1752PubMedCrossRefGoogle Scholar
  207. Williams R, Khan IM, Richardson K, Nelson L, McCarthy HE, Analbelsi T, Singhrao SK, Dowthwaite GP, Jones RE, Baird DM, Lewis H, Roberts S, Shaw HM, Dudhia J, Fairclough J, Briggs T, Archer CW (2010) Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. PLoS ONE 5(10):e13246. doi: 10.1371/journal.pone.0013246 PubMedPubMedCentralCrossRefGoogle Scholar
  208. Wojtys EM, Beaman DN, Glover RA, Janda D (1990) Innervation of the human knee joint by substance-P fibers. Arthroscopy 6(4):254–263PubMedCrossRefGoogle Scholar
  209. Zhang Y, Lu L, Furlonger C, Wu GE, Paige CJ (2000) Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat Immunol 1(5):392–397. doi: 10.1038/80826 PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Susanne Grässel
    • 1
  • Rainer H. Straub
    • 2
  • Zsuzsa Jenei-Lanzl
    • 3
  1. 1.Experimental Orthopaedics, Department of Orthopaedic SurgeryUniversity of RegensburgRegensburgGermany
  2. 2.Laboratory of Experimental Rheumatology and Neuroendocrine Immunology, Department of Internal Medicine IUniversity of RegensburgRegensburgGermany
  3. 3.Dr. Rolf M. Schwiete Research Unit for OsteoarthritisOrthopaedic University Hospital Friedrichsheim gGMBH Johann Wolfgang Goethe-UniversityFrankfurt a.M.Germany

Personalised recommendations